68.93
Schlusskurs vom Vortag:
$69.98
Offen:
$68.44
24-Stunden-Volumen:
612.97K
Relative Volume:
0.57
Marktkapitalisierung:
$3.21B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-38.99M
KGV:
-23.00
EPS:
-2.9966
Netto-Cashflow:
$-24.94M
1W Leistung:
-1.53%
1M Leistung:
+40.36%
6M Leistung:
+28.24%
1J Leistung:
+83.81%
Soleno Therapeutics Inc Stock (SLNO) Company Profile
Firmenname
Soleno Therapeutics Inc
Sektor
Branche
Telefon
650-213-8444
Adresse
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CA
Vergleichen Sie SLNO mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
SLNO
Soleno Therapeutics Inc
|
68.93 | 3.21B | 0 | -38.99M | -24.94M | -2.9966 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Soleno Therapeutics Inc Stock (SLNO) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-03-05 | Fortgesetzt | Stifel | Buy |
2024-12-02 | Bestätigt | Robert W. Baird | Outperform |
2024-12-02 | Bestätigt | Stifel | Buy |
2024-09-03 | Eingeleitet | H.C. Wainwright | Buy |
2024-05-10 | Eingeleitet | Robert W. Baird | Outperform |
2024-02-05 | Eingeleitet | Piper Sandler | Overweight |
2024-01-23 | Eingeleitet | Stifel | Buy |
2023-11-21 | Fortgesetzt | Guggenheim | Buy |
2020-09-29 | Eingeleitet | Guggenheim | Buy |
2020-01-10 | Eingeleitet | Craig Hallum | Buy |
2019-12-23 | Eingeleitet | Oppenheimer | Outperform |
2018-02-13 | Bestätigt | Maxim Group | Buy |
Alle ansehen
Soleno Therapeutics Inc Aktie (SLNO) Neueste Nachrichten
How To Trade (SLNO) - news.stocktradersdaily.com
Soleno Therapeutics appoints CBIZ CPAs as new auditor By Investing.com - Investing.com Nigeria
Soleno Therapeutics appoints CBIZ CPAs as new auditor - Investing.com Australia
Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Geode Capital Management LLC - Defense World
Franklin Resources Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Soleno launches Vykat XR (SLNO:NASDAQ) - Seeking Alpha
Soleno Therapeutics launches FDA-approved PWS treatment By Investing.com - Investing.com South Africa
Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved - MSN
Soleno Therapeutics launches FDA-approved PWS treatment - Investing.com
Soleno Therapeutics Announces VYKAT(TM) XR Launch - GlobeNewswire
Breakthrough PWS Treatment VYKAT XR Now Available: First-Ever FDA Approval for Rare Disease - Stock Titan
SLNO Stock Rallies on FDA Approval of Prader-Willi Syndrome Drug - MSN
KLP Kapitalforvaltning AS Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World
Soleno Therapeutics (SLNO) Gains FDA Approval for Prader-Willi T - GuruFocus
SLNO Quantitative Stock Analysis - Nasdaq
Capnia Inc stock soars to 52-week high, hits $74 mark - Investing.com
Soleno therapeutics SVP sells $265,156 in stock By Investing.com - Investing.com Australia
Soleno therapeutics SVP sells $265,156 in stock - Investing.com
Soleno Therapeutics, Inc. (NASDAQ:SLNO) CEO Bhatnagar Anish Sells 699,095 Shares - MarketBeat
Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod By Investing.com - Investing.com South Africa
Piper Sandler maintains $93 target on Soleno stock post-VYKAT XR nod - Investing.com
High Growth Tech Stocks To Watch In The US April 2025 - simplywall.st
Soleno Therapeutics CEO sells $35.3 million in stock By Investing.com - Investing.com India
Soleno Therapeutics CEO sells $35.3 million in stock - Investing.com Australia
Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock - Investing.com Australia
Soleno Therapeutics CEO Anish Bhatnagar sells $35.3m in stock By Investing.com - Investing.com Nigeria
Soleno Therapeutics exec sells shares worth $9.5 million By Investing.com - Investing.com South Africa
Soleno therapeutics director Matthew Pauls sells $424,797 in stock By Investing.com - Investing.com Canada
Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock - Investing.com India
Soleno therapeutics director Matthew Pauls sells $424,797 in stock - Investing.com Australia
Soleno Therapeutics exec sells $700,330 in stock - Investing.com India
Soleno Therapeutics CFO sells $4.88 million in stock - Investing.com Australia
Soleno Therapeutics Executives and Director Sell Shares - TradingView
Soleno Therapeutics CCO sells shares worth $2.48m - Investing.com
Soleno therapeutics’ SVP Yen Kristen sells $4.88 million in stock By Investing.com - Investing.com UK
Soleno Therapeutics CCO sells shares worth $2.48m By Investing.com - Investing.com UK
Soleno Therapeutics CFO sells $4.88 million in stock By Investing.com - Investing.com UK
Soleno Therapeutics Executives Sell Shares - TradingView
Soleno Therapeutics exec sells shares worth $9.5 million - Investing.com
Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock - Investing.com Australia
Soleno stock price target raised to $100 at H.C. Wainwright By Investing.com - Investing.com South Africa
Soleno stock price target raised to $100 at H.C. Wainwright - Investing.com
Soleno Therapeutics’ SWOT analysis: FDA approval boosts rare disease stock By Investing.com - Investing.com South Africa
Soleno Therapeutics Stock (SLNO) Surges on FDA Green Light for PWS Treatment - Markets Insider
Why Soleno Therapeutics Inc. (SLNO) Went Up Last Week? - Insider Monkey
10 Stocks Outperform Broader Market Last Week - Insider Monkey
Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):